Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, November 2000, p. 940-944, Vol. 7, No. 6
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Detection and Quantification of Antibodies to Newcastle Disease
Virus in Ostrich and Rhea Sera Using a Liquid Phase Blocking
Enzyme-Linked Immunosorbent Assay
Ricardo Luiz Moro
de
Sousa,1,2
Helio José
Montassier,3 and
Aramis Augusto
Pinto3,*
Graduate Program in Microbiology, Instituto
de Ciências Biomédicas, Universidade de São
Paulo,1 and Fundação de Amparo
à Pesquisa do Estado de São Paulo,2
São Paulo, and Departamento de Patologia
Veterinária, Faculdade de Ciências Agrárias e
Veterinárias, Universidade Estadual Paulista, 14870-000,
Jaboticabal,3 São Paulo, Brazil
Received 22 May 2000/Returned for modification 19 July
2000/Accepted 24 August 2000
 |
ABSTRACT |
A liquid phase blocking ELISA (LPB-ELISA) was adapted for the
detection and quantification of antibodies to Newcastle disease virus.
Sera from vaccinated and unvaccinated commercial flocks of ostriches
(Struthio camelus) and rheas (Rhea americana)
were tested. The purified and nonpurified virus used as the antigen and
the capture and detector antibodies were prepared and standardized for
this purpose. The hemagglutination-inhibition (HI) test was regarded as
the reference method. The cutoff point for the LPB-ELISA was determined
by a two-graph receiver operating characteristic analysis. The
LPB-ELISA titers regressed significantly (P < 0.0001) on the HI titers with a high correlation coefficient
(r = 0.875). The two tests showed good agreement
(
= 0.82; P < 0.0001), relative sensitivity
(90.91%) and specificity (91.18%), and accuracy (91.02%), suggesting
that they are interchangeable.
 |
INTRODUCTION |
Newcastle disease (ND) is caused by
an avian paramyxovirus (APMV-1 serotype) that belongs to the
genus Rubulavirus of the family
Paramyxoviridae (19). Newcastle disease
virus (NDV) occurs worldwide and has a considerable economic
impact on the world poultry industry, ranging from losses due to
disease and the expense of vaccination to the significant cost of
diagnostic laboratory investigations (14). The breeding of
ratites (ostriches, emus, and rheas) has expanded considerably
all over the world in recent years. They are susceptible to
several diseases of domestic fowl, including ND (15, 20).
Efforts to control and prevent ND through efficient vaccination
programs and corresponding serological monitoring are constant.
The hemagglutination-inhibition (HI) test is still the most widely used
conventional serological method for measuring anti-NDV antibody levels
in poultry sera, and it is considered the standard laboratory test for
this disease (30). However, sera from other species tend to
give a high incidence of false-positive results. And although the
number of nonspecific agglutination reactions can be reduced by
pretreatment with heat and kaolin, these procedures decrease the
sensitivity of this test (28).
Indirect enzyme-linked immunosorbent assays (I-ELISA) have been
developed, evaluated, and well correlated to the HI test for serodiagnosis of NDV in poultry (4, 8, 18). In spite of their high sensitivity, easy standardization, lack of requirement for
serum pretreatment, and possible computerization of the system, these
assays have the disadvantage of not being applicable to the testing of
ratite sera in a single system unless anti-ratite species conjugates
are used in place of an anti-chicken conjugate (5, 28).
An APMV-1-specific monoclonal antibody blocking ELISA with the ability
to test sera from exotic or wild avian species for NDV-specific
antibodies in serial twofold dilutions or a single dilution has been
described (9, 13). However, production and maintenance of
hybridoma cells are time-consuming and sometimes expensive for
laboratories with limited facilities. Moreover, assays with a single
serum dilution are faster and more practical than serial dilution
assays (7, 25, 26).
Additionally, the determination of a suitable cutoff point in ELISA and
other quantitative serodiagnostic tests becomes a useful tool of
analysis for better test performance as well as reliable sensitivity
and specificity, principally when no specific assumptions are made
concerning the distribution of the ELISA data (30). If
sensitivity and specificity are equally important, the two-graph
receiver operating characteristic (TG-ROC) method is appropriate
(11).
In this study a liquid phase blocking ELISA (LPB-ELISA) with polyclonal
immunoreagents was adapted for the detection and quantification of
antibodies to NDV in sera from vaccinated and unvaccinated commercial
flocks of ostriches (Struthio camelus) and rheas (Rhea americana) in a single system. Furthermore, TG-ROC analysis was carried out to determine the optimum cutoff point for the LPB-ELISA. Values obtained in the HI test and LPB-ELISA were compared for relative
sensitivity and specificity, predictive values, accuracy, agreement,
and likelihood ratio by linear regression analysis and determination of
the correlation coefficient.
 |
MATERIALS AND METHODS |
Virus antigen.
The NDV live vaccine strain La Sota was
propagated in the allantoic cavities of 9- to 11-day-old embryonated
specific-pathogen-free chicken eggs by inoculation with 0.1 ml of
infectious allantoic fluid containing 107.4 median embryo
infective doses (EID50). The infected allantoic fluid (IAF)
was harvested and clarified by centrifugation at 8,000 × g for 1 h at 4°C in a Sorvall SLA-1500 rotor (Sorvall
Products, Newtown, Conn.). The reciprocal of the hemagglutination (HA)
titer of the stock NDV harvested was 2,048. Approximately 800 ml of IAF
was subjected to protein precipitation with 8.7% (wt/vol) polyethylene
glycol (PEG-8000) (Sigma Chemical Co., St. Louis, Mo.) and 2.7%
(wt/vol) sodium chloride (NaCl) under gentle stirring for 18 h at
4°C. The concentrated IAF was centrifuged at 4°C for 1 h at
8,000 × g in a Sorvall SLA-1500 rotor, and the pellet
was resuspended in 30 ml of TNE buffer (10 mM Tris, 150 mM NaCl, 1 mM
EDTA [pH 7.4]). Next, 10-ml volumes of concentrated virus suspension were layered over a discontinuous 30 to 55% (wt/vol) sucrose gradient in TNE buffer. The gradient was ultracentrifuged at 4°C for 4 h
at 96,000 × g in a Sorvall AH-629 rotor. The 1-ml
fractions from each tube which highly adsorbed at 254 nm (viral RNA)
and 280 nm (total protein) were pooled and run through a second,
identical gradient. Fractions collected from the second run of
gradients were pooled, diluted with TNE buffer, and ultracentrifuged at 4°C for 4 h at 96,000 × g in a Sorvall AH-629
rotor for sucrose removal. The pellet was resuspended in 4 ml of TNE
buffer, subsequently layered on top of a continuous 20 to 55% (wt/vol)
sucrose gradient (TNE buffer), and ultracentrifuged at 96,000 × g for 12 h at 4°C in a Sorvall AH-629 rotor. The
fractions collected as described above were pooled and centrifuged for
sucrose removal. The final pellet was resuspended in 4 ml of TNE
buffer, and the protein concentration was estimated by a bicinchoninic
acid (BCA) assay (23). The resultant TNE suspension
containing the purified viral antigen was stored at
70°C in 0.30-ml
aliquots. The efficiency of all purification processes with regard to
viral hemagglutinin reactivity was monitored by an HA test using
aliquots from each viral purification step. The IAF clarified by
centrifugation at 8,000 × g for 1 h at 4°C in a
Sorvall SLA-1500 rotor was used as nonpurified antigen in the LPB-ELISA
and the HI test.
Capture antibody.
The capture antibody was prepared by the
immunization of three guinea pigs with purified NDV (6).
Previously the purified NDV was subjected to an adsorption-elution
assay with chicken red blood cells (22) in order to achieve
a higher purity level by removing undesirable IAF-derived residual
protein components from the purified NDV suspension. The resultant
guinea pig anti-NDV serum was inactivated at 56°C for 30 min,
titrated by an HI test, and stored at
20°C. The specific reactivity
of the capture antibody to NDV was tested by checking nonspecific
reactions between the guinea pig antiserum and noninfected allantoic
fluid at a protein concentration of 1 µg/ml in coating buffer using
an I-ELISA (10) with a preprepared rabbit anti-guinea pig
immunoglobulin G (IgG)-horseradish peroxidase conjugate diluted 1:1,000
in phosphate-buffered saline (PBS).
Detector antibody.
The chicken anti-NDV serum was used as
the detector antibody as described previously (26). Briefly,
the purified NDV was subjected to the procedure described above for
enhancing the purity level. The chicken anti-NDV serum obtained was
inactivated at 56°C for 30 min, titrated by an HI test, and stored at
20°C. The reactivity of the detector antibody to noninfected
allantoic fluid was also determined by an I-ELISA (10) as
described above, using a rabbit anti-chicken IgG-horseradish peroxidase
conjugate prepared as described below and diluted 1:2,000 in PBS.
Conjugate.
A rabbit anti-chicken IgG coupled to horseradish
peroxidase (Sigma Chemical Co.) was used as the conjugate (18,
29). Possible reactivity between the conjugate and ratite sera
was tested by a double antibody sandwich ELISA (6) using two
serum pools consisting of a mixture of three sera, one from each ratite
species, showing high HI titers.
Test sera.
A total of 78 ratite serum samples from ostrich
and rhea breeder farms, divided into four groups, were tested by both
the HI test and the LPB-ELISA. Twenty-five of the sera were from a population of unvaccinated 3-month-old ostrich chicks, 11 were obtained from vaccinated 3.5-month-old ostrich chicks, 11 were from
unvaccinated 3-month-old rhea chicks, and 31 were from vaccinated 4-month-old rhea chicks. The birds were vaccinated with the La Sota
live strain of NDV by eye drop instillation and were bled 20 days after
the vaccination. No clinical signs of disease were observed in any of
the birds tested.
HI test.
The micro-beta HI test was performed using 4 HA
units of the La Sota vaccine strain of NDV (clarified IAF) and 1%
chicken red blood cells (2). A duplicate twofold dilution
series of each test serum was made, and titers were expressed as
log2 values of the highest reciprocal of the dilution which
showed hemagglutination inhibition. Titers equal to or greater than 3 log2 were considered positive results. Each test serum
sample was pretreated at 56°C for 30 min and then incubated with
kaolin at 37°C for 30 min to extract nonspecific inhibitors
(28).
LPB-ELISA.
The LPB-ELISA was performed as described by
Hamblin et al. (12) for foot-and-mouth disease antibodies,
with some modifications for the detection and quantification of NDV
antibodies with regard to the percentage of blocking or inhibition of
each test serum.
Briefly, optimal dilutions of guinea pig anti-NDV serum, chicken
anti-NDV serum, and nonpurified antigen were determined using checkerboard titration (6). The working dilution of the
rabbit anti-chicken IgG conjugated to horseradish peroxidase was
obtained by a direct ELISA (27).
Flat-bottom 96-well microtiter plates (Immunoplate Maxisorp F96; Nunc,
Roskilde, Denmark) were used. All reagents were delivered
in 50-µl
volumes.
The microplate wells were coated with an optimal dilution (1:4,000) of
guinea pig anti-NDV serum in 0.05 M carbonate-bicarbonate
buffer (pH
9.6) and incubated overnight at 4°C to provide a trapping
antibody.
After four washes with PBS containing 0.05% Tween 20,
which was the
wash buffer used throughout, the plates were blocked
using 100 µl of
PBS containing 5% normal guinea pig serum and
10% skim milk
powder/well to minimize nonspecific binding sites.
This was followed by
a 45-min incubation at 37°C. The liquid phase
was carried out in
U-bottom 96-well microtiter plates (Nunc),
and a mixture of nonpurified
NDV La Sota at a constant predetermined
dilution (1:8) in PBS and
duplicates of 1:8-diluted test sera
in PBS was used. After incubation
at 37°C for 90 min, 50-µl volumes
of test serum-virus mixtures were
transferred from the carrier
plates to the ELISA plates and incubated
at 37°C for 60 min. Thereafter,
ELISA plates were washed as before,
and a pretitrated optimal
dilution (1:1,000) of chicken anti-NDV serum
in PBS containing
0.05% Tween 20, 5% normal guinea pig serum, and
10% skim milk
powder (PBSTGM) was added. The plates were incubated for
60 min
at 37°C and then washed. A pretitrated optimal dilution
(1:2,000)
of the conjugate in PBSTGM was added to measure the amount of
detector antibody complexed with the virus which had been trapped
by
the capture antibody. After incubation for 60 min at 37°C,
the plates
were again washed as described above, a mixture of
0.006%
H
2O
2 and 0.4 mg of
o-phenylenediamine (Sigma Chemical Co.)/ml
in 0.1 M
Na
2HPO
4-0.1 M citric acid buffer (pH 5.0) was
added to
all the wells, and the reaction was allowed to develop for 15
min at room temperature. The reaction was then stopped by the
addition
of 2 M HCl. Plates were read spectrophotometrically at
490 nm on an
ELISA plate reader (Bio-Rad, Hercules, Calif.).
On each plate, 22 wells were reserved for the antigen control with no
test sera added, and they were used to define the mean
optical density
corresponding to a 100% detector antibody bound
to the antigen (max
OD). The degree of blocking or inhibition
for each test serum was then
calculated by the following formula:
percentage of inhibiton (PI) = (max OD

sample OD)/(max OD)]
×
100.
Calculation of LPB-ELISA cutoff point.
The cutoff point was
determined by TG-ROC analysis (11, 28, 30), which is,
briefly, a plot of the test sensitivity (Se) and specificity (Sp)
against the cutoff (threshold) value (PI value), the latter being an
independent variable. At the intersection point of the two graphs,
known as the point of equivalence, the assay Se is equal to the assay
Sp. This point was selected as the cutoff point (CTP) for the
LPB-ELISA, and titers expressed as PIs equal to or greater than the CTP
were regarded as positive.
Statistical analysis.
The HI and LPB-ELISA titers were
analyzed to determine relative sensitivity and specificity, predictive
values, and accuracy. Sensitivity was defined as the proportion of
HI-positive samples that were correctly identified by LPB-ELISA, and
specificity was defined as the proportion of correctly identified
HI-negative samples (15). Predictive values (positive and
negative) were defined as the probability that a LPB-ELISA result
reflected the true HI status. Accuracy was defined as the proportion of
two tests, both positive and negative, which were corrected. Fisher's exact test was used to compare the sensitivity and the specificity of
the two tests. LPB-ELISA values were linearly regressed on HI titers,
and the correlation coefficient (Pearson's r) was obtained (4). Kappa (
) was calculated to measure the strength of
the agreement between the two methods (24). The likelihood
ratio at a 95% confidence interval (CI) was used to express the
probability that LPB-ELISA results came from birds with opposed HI
results. For this purpose, the likelihood ratio for a positive test was defined as sensitivity/(1
specificity) and the likelihood ratio for a negative test was defined as (1
sensitivity)/specificity (24). StatsDirect (CamCode, Ashwell, England) and EXCEL 97 (Microsoft, Bellevue, Wash.) were used for the calculations.
 |
RESULTS |
Capture and detector antibodies and conjugate nonspecific
reactivity.
The guinea pig antiserum tested by I-ELISA at a 1:8
dilution showed a mean OD of 0.088 at 490 nm, and the respective
blank mean OD was 0.030; the chicken antiserum at a 1:10 dilution
showed a mean OD of 0.040, and the corresponding blank mean OD was
0.035. However, when the noninfected allantoic fluid was changed to
IAF, mean OD readings increased to 1.991 for the guinea pig antiserum and 1.755 for the chicken antiserum; the blank mean OD readings were 0.035 and 0.038, respectively. Similarly, the conjugate at a
1:2,000 dilution exhibited a mean OD of 0.069 at 490 nm to a 1:8-diluted ostrich serum pool and a mean OD of 0.071 to a 1:8-diluted rhea serum pool by a double antibody sandwich ELISA. However, mean OD
readings increased to 2.790 when ratite serum pools were replaced by a
detector antiserum at a 1:8 dilution.
LPB-ELISA cutoff point.
The proportion of HI-seropositive (HI
titer,
3 log2) ratites was 56%. The sensitivity and
specificity curves of the LPB-ELISA as functions of the cutoff points
used are shown in Fig. 1. By TG-ROC
analysis, the intersection point of the two curves indicates that with
a cutoff point of 29.00% (PI value), the LPB-ELISA presents a relative
Se and Sp of approximately 0.93, or 93% (point of equivalence). The
selection of this cutoff point is based on count data (nonparametric approach), because TG-ROC indicated deviations from a normal
distribution. The accuracy level for this analysis was 95%.
Thereafter, a PI of
29.00% was regarded as indicating an
LPB-ELISA-positive serum, and a PI of <29.00% was considered as
indicating an LPB-ELISA-negative serum.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Curves of relative Se and Sp of the LPB-ELISA using
TG-ROC analysis. The intersection point of the two curves indicates the
cutoff point (PI value = 29.00%) at which Se = Sp = 0.93 (dotted and dashed horizontal line). The accuracy level used was
95%.
|
|
Relationship between the LPB-ELISA and the HI test.
The
relationship between the LPB-ELISA and the HI test is shown in Table
1. Of all the sera tested, 40 (51.28%)
were positive and 31 (39.74%) were negative with both the LPB-ELISA
and the HI test. Three sera (3.85%) were positive only with the
LPB-ELISA, whereas four (5.13%) were positive only with the HI test
(Table 1). The relative sensitivity of the LPB-ELISA was 90.91%, and the specificity was 91.18% (P < 0.0001); the
accuracy between the two tests was 91.02%. The positive predictive
value (93.02%) and the negative predictive value (88.57%) are also
shown.
There was good agreement between the two serological methods (

= 0.82) (
P < 0.0001). By convention, kappa values of
0.8 to
1.0 express almost perfect agreement between tests
(
24).
A close correlation (
r = 0.875) was found between the
LPB-ELISA and HI titers (
P < 0.0001) by a linear
regression analysis
(Fig.
2).
The likelihood ratio for a positive test (LR+) was 10.30 (95% CI, 3.94 to 29.94), meaning that an LPB-ELISA titer of

29.00%
was 10 times as
likely to have come from an HI-positive bird as
from an HI-negative
bird. The likelihood ratio for a negative
test (LR

) was 0.1 (95% CI,
0.04 to 0.23), meaning that an LPB-ELISA
titer of <29.00% was 1/10 as
likely to have come from an HI-positive
bird as from an HI-negative
bird. LR+ and LR

are graphically
displayed in Fig.
3.
 |
DISCUSSION |
In order to overcome the problems of routine NDV serology for
ratites species, an LPB-ELISA was used and evaluated for the detection
and titration of NDV-specific antibodies. The basic procedure for the
LPB-ELISA was that used by Hamblin et al. (12) and Cardoso
et al. (7), with the optimal concentrations of reagents
being determined by checkerboard titration.
The usefulness of the ELISA based on the indirect method has been
evaluated and correlated to the HI test many times. Brown et al.
(4) obtained a correlation coefficient of 0.85 and a kappa
value of 0.84 as well as high relative sensitivity (98.2%) and
specificity (91.7%). A similar correlation coefficient
(r = 0.85) was reported by Cvelic-Cabrilo et al.
(8); this was somewhat better than the 0.75 calculated by
Adair et al. (1). However, in both cases, the authors tested
only chicken sera, using a commercial anti-chicken conjugate.
Cadman et al. (5) compared the reactivity of ostrich sera to
NDV by an I-ELISA and an HI test. Using a peroxidase-labeled goat
anti-ostrich IgG, a sigmoidal relationship (r = 0.612)
(3rd-degree polynomial) was found when serum samples from vaccinated
and naturally infected birds were tested. Nevertheless, this I-ELISA
could not be used for sera from other species, limiting its
applicability to laboratory routine.
Our significant correlation result also confirms the report of Jestin
et al. (13) that a PMV-1-specific monoclonal antibody blocking ELISA (B-ELISA) to test a twofold dilution series of sera from
vaccinated specific-pathogen-free chickens and Muscovy ducks obtained a
high coefficient correlation (r = 0.90)
(P < 0.001). Czifra et al. (9) described a
B-ELISA to test sera from chickens experimentally infected with NDV,
chickens vaccinated against NDV, and field samples from chickens and
turkeys; high sensitivity was found relative to either the HI test or
the I-ELISA (mean, >90%), and the B-ELISA was consistently more
sensitive than the HI test.
Recently, Koch et al. (15) used a similar B-ELISA to test
211 ostrich sera in a twofold dilution series; a kappa value slightly greater (
= 0.85) than that calculated in the present study was found, but a lower correlation was found (r = 0.71);
sensitivity relative to the HI test was 91%, and relative specificity
was 96%. The positive predictive value (97%) was greater than that described here, but a similar negative predictive value (87%) was observed, although predictive values are dependent on disease prevalence. The false-positive rate among the sera examined was lower
(1.42%) than that found in our study (3.85%), which included two ostrich sera and one rhea serum, while the false-negative rate
(5.21%) was similar to our findings (5.13%), including two sera for
each ratite species.
Polyclonal immunoreagents (capture and detector antibodies) are cheaper
than monoclonal antibodies for the B-ELISA, and the LPB-ELISA is easy
to perform, dispensing with special skills and showing adequate
applicability, as observed in our study, for testing sera from
different avian species, while excluding possible nonspecific reactions
to allantoic fluid components or reactivity between the sera tested and
the conjugate. Probably the further purification of purified NDV by
red-cell adsorption-elution (22) before the production of
capture and detector antiserum enhanced the effectiveness of antigen
purification. Furthermore, the use of a single untreated serum
dilution, as described, in our test system is more practical than
serial dilution (28) because it decreases the preparation
time and the number of microtiter plates required. The working test
serum dilution of 1:8 was chosen as being the minimum serum dilution at
which no gelation was observed during the liquid phase incubation for
rhea serum-virus mixtures, thus enabling these suspensions to be
transferred to solid phase microplates more easily. Probably this
phenomenon is related to high-fat or low-protein diets offered to the
ratites surveyed (16, 17); it continued even when the
respective sera were submitted to clarification by centrifugation
(10,000 × g for 10 min at 4°C). Koch et al.
(15) used a starting ostrich serum dilution of 1:10 for
B-ELISA, while Schelling et al. (21) assayed poultry sera
for NDV antibodies by a similar B-ELISA using a sample dilution of
1:10.
On the other hand, the determination by TG-ROC analysis of a suitable
cutoff point for obtaining balanced Se and Sp or a specific Se or Sp
provided a useful tool for obtaining better performance of the test,
particularly with data deviating from a normal distribution. The TG-ROC
analysis used to compare the Se and Sp of an I-ELISA with those of an
HI test using sera from vaccinated and unvaccinated ostriches showed
that the I-ELISA was superior to the HI test in both Se and Sp, with
both Se and Sp equaling 97.2% at the cutoff point for the I-ELISA
(28). Moreover, because likelihood ratio determination is
derived from the test Se and Sp only, it is unaffected by disease
prevalence, making it an especially stable expression of test
performance as found here.
In a previous study (26) we used a similar LPB-ELISA to
detect antibodies against NDV in sera from vaccinated and unvaccinated partridges. High relative sensitivity (96.82%) and specificity (90.54%), as well as good accuracy (94.5%), were found. The
correlation coefficient (r = 0.8217; P < 0.0005) was lower than that described here. However, a cutoff point
determination was derived from the mean titer of control birds plus two
times the standard deviation, a procedure widely used for this purpose
(11). In fact, this approach leads automatically to an Sp of
97.5%, and this assumption holds true only in the case of a
normally distributed test variable, as shown by Barajas-Rojas et al.
(3). Thus, this procedure, without any indication of the
resulting test Se, does not reflect the major function of a cutoff
value, which is to distinguish between seropositive and seronegative
individuals (11). In contrast, TG-ROC analysis provides an
appropriate selection of cutoff values for obtaining Se and Sp for both
parametric and nonparametric approaches.
The LPB-ELISA described above, together with TG-ROC analysis for cutoff
determination, showed statistically significant test indices compared
with those from earlier studies, particularly a close correlation
coefficient and a high level of agreement with the HI test, emphasizing
the diagnostic validity of the LPB-ELISA. Therefore, LPB-ELISA was
demonstrated to be a very useful method and able to replace the
B-ELISA, the I-ELISA, and the HI test in seroepidemiological surveys or
vaccinal monitoring for the determination of antibody levels to NDV in
sera from ratites without a serum pretreatment requirement.
 |
ACKNOWLEDGMENTS |
We thank M. L. F. Tamanini and A. E. G. Lima
for technical assistance.
This work was supported by the Fundação de Amparo à Pesquisa
do Estado de São Paulo (FAPESP) (grant 98/11301-0) and by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (grant 521722/93-4/NV).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratório de
Virologia e Imunologia, Departamento de Patologia Veterinária,
Faculdade de Ciências Agrárias e Veterinárias, Universidade
Estadual Paulista (UNESP), Via de Acesso Prof. Paulo Donato Castellane,
Km 05, 14870-000, Jaboticabal, São Paulo, Brazil. Phone:
55-16-3232500, ext. 225. Fax: 55-16-3224275. E-mail:
aramisap{at}asbyte.com.br.
 |
REFERENCES |
| 1.
|
Adair, B. M.,
M. S. McNulty,
D. Todd,
T. J. Connor, and K. Burns.
1989.
Quantitative estimation of Newcastle disease virus antibody levels in chickens and turkeys by ELISA.
Avian Pathol.
18:175-192[Medline].
|
| 2.
|
Allan, W. H., and R. E. Gough.
1974.
A standard hemagglutination inhibition test for Newcastle disease. 1. A comparison of macro and micro method.
Vet. Rec.
95:120-123[Medline].
|
| 3.
|
Barajas-Rojas, J. A.,
H. P. Riemann, and C. E. Franti.
1993.
Notes about determining the cut-off value in enzyme-linked immunosorbent assay (ELISA).
Prev. Vet. Med.
15:231-233[CrossRef].
|
| 4.
|
Brown, J.,
R. S. Resurreccion, and T. G. Dickson.
1990.
The relationship between the hemagglutination-inhibition test and the enzyme-linked immunosorbent assay for the detection of antibody to Newcastle disease.
Avian Dis.
34:585-587[CrossRef][Medline].
|
| 5.
|
Cadman, H. F.,
P. J. Kelly,
N. D. De Angelis,
C. Rohde,
N. Collins, and T. Zulu.
1997.
Comparison of enzyme-linked immunosorbent assay and haemagglutination inhibition test for the detection of antibodies against Newcastle disease virus in ostriches (Struthio camelus).
Avian Pathol.
26:357-363[Medline].
|
| 6.
|
Cardoso, T. C.,
R. L. M. Sousa,
A. C. Alessi,
H. J. Montassier, and A. A. Pinto.
1998.
A double antibody sandwich ELISA for rapid diagnosis of virus infection and to measure the humoral response against infectious bursal disease on clinical material.
Avian Pathol.
27:450-454[Medline].
|
| 7.
|
Cardoso, T. C.,
R. L. M. Sousa,
C. Oliveira,
G. Strighini, and A. A. Pinto.
1999.
A liquid phase blocking ELISA for the detection of antibodies against infectious bronchitis virus.
Braz. J. Med. Biol. Res.
32:747-752[Medline].
|
| 8.
|
Cvelic-Cabrilo, V.,
H. Mazija,
Z. Bidin, and W. L. Ragland.
1992.
Correlation of hemagglutination inhibition and enzyme-linked immunosorbent assays for antibodies to Newcastle disease virus.
Avian Pathol.
21:509-512[Medline].
|
| 9.
|
Czifra, G.,
M. Nilsson,
D. J. Alexander,
R. Manvell,
S. Kecskeméti, and B. E. Engström.
1996.
Detection of PMV-1 specific antibodies with a monoclonal antibody blocking enzyme-linked immunosorbent assay.
Avian Pathol.
25:691-703[Medline].
|
| 10.
|
Engvall, E., and P. Perlmann.
1972.
Enzyme linked immunosorbent assay (ELISA). III. Quantitation of specific antibodies by enzyme-linked anti-immunoglobulin in antigen coated tubes.
J. Immunol.
109:129-135[Abstract/Free Full Text].
|
| 11.
|
Greiner, M.,
D. Sohr, and P. Göbel.
1995.
A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests.
J. Immunol. Methods
185:123-132[CrossRef][Medline].
|
| 12.
|
Hamblin, C.,
I. T. R. Barnett, and R. S. Hedger.
1986.
A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA.
J. Immunol. Methods
93:115-122[CrossRef][Medline].
|
| 13.
|
Jestin, V.,
M. Cherbonnel,
R. L'Hospitalier, and G. Bennejean.
1989.
An ELISA blocking test using a peroxidase-labelled anti-HN monoclonal antibody for the specific titration of antibodies to avian paramyxovirus type 1 (PMV1).
Arch Virol.
105:199-208[CrossRef][Medline].
|
| 14.
|
Jørgensen, P. H.,
J. Herczeg,
B. Lomniczi,
R. J. Manvell,
E. Holm, and D. J. Alexander.
1998.
Isolation and characterization of avian paramyxovirus type 1 (Newcastle disease) viruses from a flock of ostriches (Struthio camelus) and emus (Dromaius novaehollandiae) in Europe with inconsistent serology.
Avian Pathol.
27:352-358[Medline].
|
| 15.
|
Koch, G.,
G. Czifra, and B. E. Engström.
1998.
Detection of Newcastle disease virus-specific antibodies in ostrich sera by three serological methods.
Vet. Rec.
4:10-12.
|
| 16.
|
Mushi, E. Z.,
M. G. Binta,
R. G. Chabo,
J. F. W. Isa, and L. Modisa.
1998.
Serum biochemical values of farmed ostrich (Struthio camelus) in Botswana.
Onderstepoort J. Vet. Res.
65:189-193[Medline].
|
| 17.
|
Perry, M. C.,
H. H. Obrecht,
B. K. Williams, and W. J. Kunzel.
1986.
Blood chemistry and haematocrit of captive and wild canvasbacks.
J. Wildl. Manag.
50:435-444.
|
| 18.
|
Richtzenhain, L. J.,
A. C. Paulillo,
A. A. Pinto, and S. N. Kronca.
1993.
Relation between the hemagglutination inhibition test and the indirect ELISA in the serologic monitoring of laying hens submitted to different systems of vaccination against Newcastle disease.
Rev. Microbiol.
24:187-191.
|
| 19.
|
Rima, B.,
D. J. Alexander,
M. A. Billeter,
P. L. Collins,
D. W. Kingsbury,
M. A. Lipkind,
Y. Nagai,
C. Orvell,
C. R. Pringle, and V. Ter Meulen.
1995.
The Paramyxoviridae. Virus taxonomy, p. 268-274.
In
C. M. Murphy, D. H. L. Fauquet, A. S. Bishop, A. W. Ghabrial, G. P. Jarvis, M. A. Martelli, M. A. Mayo, and M. D. Summers (ed.), Sixth report of the International Committee on Taxonomy of Viruses. Springer-Verlag Wien, Vienna, Austria.
|
| 20.
|
Samberg, V.,
D. V. Hadash,
B. Perelman, and M. Meroz.
1989.
Newcastle disease in ostriches (Struthio camelus): field case and experimental infection.
Avian Pathol.
18:221-226.
|
| 21.
|
Schelling, E.,
B. Thür,
C. Griot, and L. Andigé.
1999.
Epidemiological study of Newcastle disease in backyard poultry and wild bird populations in Switzerland.
Avian Pathol.
28:263-272[CrossRef].
|
| 22.
|
Sheffield, F. W.,
W. Smith, and G. Belyavin.
1954.
Purification of influenza virus by red-cell adsorption and elution.
Br. J. Exp. Pathol.
35:214-222.
|
| 23.
|
Smith, P. K.,
R. L. Krohn,
G. T. Hermanson,
A. K. Mallia,
F. H. Gartner,
M. D. Provenzano,
E. K. Fujimoto,
N. M. Goeke,
B. J. Olson, and D. C. Klenk.
1986.
Measurement of protein using bicinchoninic acid.
Anal. Biochem.
150:76-85.
|
| 24.
|
Smith, R. D.
1995.
Veterinary clinical epidemiology: a problem-oriented approach, 2nd ed.
CRC Press, Inc., Boca Raton, Fla.
|
| 25.
|
Snyder, D. B.,
W. W. Marquardt,
E. T. Mallinson, and E. Russek.
1983.
Rapid serological profiling by enzyme-linked immunosorbent assay and conventional methods for avian serology.
Avian Dis.
27:161-170[CrossRef][Medline].
|
| 26.
|
Sousa, R. L. M.,
T. C. Cardoso,
A. C. Paulillo,
H. J. Montassier, and A. A. Pinto.
1999.
Antibody response to Newcastle disease vaccination in a flock of young partridges (Rhynchotus rufescens).
J. Zoo Wildl. Med.
30:459-461[Medline].
|
| 27.
|
Voller, A.,
D. E. Bidwell, and A. Bartlett.
1976.
Enzyme immunoassay in diagnostic medicine. Theory and practice.
Bull W. H. O.
53:55-65[Medline].
|
| 28.
|
Williams, R.,
C. H. Boshoff,
D. Verwoerd,
M. Schoeman,
A. V. Wyk,
T. H. Gerdes, and K. Ross.
1997.
Detection of antibodies to Newcastle disease virus in ostriches (Struthio camelus) by an indirect ELISA.
Avian Dis.
41:864-869[CrossRef][Medline].
|
| 29.
|
Wilson, M. B., and P. K. Nakane.
1978.
Recent developments in periodate method conjugating horsedish peroxidase (HRPO) to antibodies, p. 215.
In
W. Knapp, L. Holubar, and G. Wick (ed.), Immunofluorescence and related techniques. Elsevier-North Holland Biomedicas, Amsterdam, The Netherlands.
|
| 30.
|
Xu, H.,
J. Lohr, and M. Greiner.
1997.
The selection of ELISA cut-off points for testing antibody to Newcastle disease by two-graph receiver operating characteristic (TG-ROC) analysis.
J. Immunol. Methods
208:61-64[CrossRef][Medline].
|
Clinical and Diagnostic Laboratory Immunology, November 2000, p. 940-944, Vol. 7, No. 6
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.